Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Stevens, London

David John Stevens, London GB

Patent application numberDescriptionPublished
20090265114Influenza virus neuraminidase crystal structure and their use thereof - The invention relates to crystals of the influenza virus neuraminidase protein, their structures and their use.10-22-2009

Julian Stevens, London GB

Patent application numberDescriptionPublished
20120298866SNOWMOBILE AND METHOD FOR DRIVING A SNOWMOBILE - A snowmobile is disclosed, the snowmobile comprising a terrain visualization device. The device comprises a mounting structure fixed to the snowmobile, and a light emitting unit attached to the mounting structure. The light emitting unit is configured to project a predetermined contrast pattern onto terrain in front of the snowmobile in use. A method for driving a snowmobile across terrain is also disclosed, the method comprising projecting a predetermined contrast pattern onto the terrain using a light emitting unit while driving the snowmobile across the terrain, so that the topography of the terrain can be determined from distortion of the contrast pattern.11-29-2012
20120298887TERRAIN VISUALIZATION DEVICE - A terrain visualization device is disclosed, the device comprising a wearable mounting structure adapted to be fixed to a user. The device also includes a light emitting unit attached to the mounting structure and configured to project a predetermined contrast pattern onto terrain when the mounting structure is fixed to a user. Also disclosed is a method for traversing terrain comprising fixing a wearable mounting structure to a user, the mounting structure having a light emitting unit attached thereto, traversing the terrain, and projecting a predetermined contrast pattern onto the terrain using the light emitting unit, so that the topography of the terrain can be determined from distortion of the contrast pattern. A method for illuminating a ski run is also disclosed.11-29-2012

Julian D. Stevens, London GB

Patent application numberDescriptionPublished
20090292275HIGH-ORDER OPTICAL CORRECTION DURING CORNEAL LASER SURGERY - Systems and methods related to corneal ablation for treatment of one or more high-order optical aberrations are provided. A method includes providing a defect-correcting prescription, determining an ablation profile to impose the prescription on the cornea, and determining a sequence of laser-energy ablations to impose the ablation profile on the cornea. The prescription comprises a high-order optical correction. The ablation profile comprises a first-segment profile and a second-segment profile. The second-segment profile corresponds to at least one high-order optical correction. The ablation sequence comprises applying ablations corresponding to the first-segment profile prior to applying ablations corresponding to the second-segment profile.11-26-2009

Martin Stevens, London GB

Patent application numberDescriptionPublished
20090322588METHODS AND APPARATUS FOR COORDINATING ADS-B WITH MODE S SSR AND/OR HAVING SINGLE LINK COMMUNICATION - Methods and apparatus for an ADS-B system having a single link for communication and/or ADS-B/Mode-S coordination. With this arrangement, the system communication is efficiently used.12-31-2009

Molly Stevens, London GB

Patent application numberDescriptionPublished
20110123592Biomaterials - The invention relates to a biomaterial having a latent form of a growth factor immobilised thereon, and to a method of producing the biomaterial, comprising immobilising the latent form of the growth factor on the biomaterial. The biomaterial may be used in medicine, such as in tissue regeneration or repair.05-26-2011
20120070852ASSAY - The present invention relates to an assay for transferases. The assay comprises a first moiety comprising a transferase substrate and a second moiety capable of binding to the transferase substrate after it has been acted on by the transferase. One of the first and second moieties comprises a fluorophore and the other of the first and second moieties causes a change in fluorescence of the fluorophore. Thus, when the second moiety binds the transferase substrate after it has been acted on by the transferase, a change in fluorescence can be detected. The assay allows for agents that modulate the activity of the transferase to be screened.03-22-2012

Molly M. Stevens, London GB

Molly Morag Stevens, London GB

Patent application numberDescriptionPublished
20090208428Bioactive Glass - The present invention relates to a bioactive glass comprising strontium and silicon dioxide, processes for the production of the bioactive glass and the use of the bioactive glass in medicine.08-20-2009
20110009511Glass Polycarboxylate Cements - The present invention relates to glass compositions for use in formation of polycarboxylate cements and polycarboxylate cements comprising these glasses, wherein the glasses comprise SiO01-13-2011
20110045052Bioactive Glass Coatings - The present invention relates to bioactive glass coatings. In particular, the present invention relates to bioactive glass coatings for Ti6Al4V alloys and chrome cobalt alloys, wherein the thermal expansion coefficient of the glass coating is matched to that of the alloy. Such coatings have a particular application in the field of medical prosthetics. The bioactive glass comprises (in mol %) 35-53 SiO2; 2-11 Na20; at least 2% of each of CaO, MgO and K20; 0-15 ZnO; 0-2 B202 and 0-9 P205.02-24-2011
20110077380CARBOHYDRATE LACTONE POLYMERS - The present invention relates to a novel carbohydrate lactone, functionalized aliphatic polyesters and copolymers formed therefrom, and processes for the preparation thereof from renewable resources.03-31-2011
20110142902Hypoxia Inducing Factor (HIF) Stabilising Glasses - The present invention relates to a glass composition formulated to provide the controlled release of certain transition metal ions to regulate the cellular hypoxia pathway and the use of these hypoxia-pathway regulating glasses in medicine and in biomedical research, including in the repair, restoration or regeneration of diseased or damaged tissue.06-16-2011

Nicholas Martin Stevens, London GB

Patent application numberDescriptionPublished
20100228680DETERMINING RELATIVE PERFORMANCE - A method and system for evaluating a public sector organization includes identifying at least one outcome measure and at least one cost-effectiveness measure for a public sector organization; obtaining measurements associated with the measure; and determining a relative public performance measure of the public sector organization based on the measurements.09-09-2010